Variation in prostate cancer growth rates in an MRI-based active surveillance cohort

Question What is the population distribution of growth rates and the natural history of prostate cancer? Findings Prostate cancer typically grows slowly, with considerable variation between individuals. On average, lesions take 17 years to grow from initiation to an MRI-detectable size. Clinical relevance Small lesions undetectable on MRI may take many years to reach a clinically significant size, posing a challenge for early detection, as it increases the risk of detecting indolent lesions that may never cause harm.

Authors

Institutions

Publication Details

Journal
European Radiology
Published
2026-01-16
DOI
https://doi.org/10.1007/s00330-025-12248-y
Citations
1
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
36.44

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Variation in prostate cancer growth rates in an MRI-based active surveillance cohort

Caroline M. Moore, Helen Smith, Bharath Narayanan, Nora Pashayan et al.
1 citations
European Radiology
Prostate Cancer Diagnosis and Treatment
36.44
article

Variation in prostate cancer growth rates in an MRI-based active surveillance cohort

Caroline M. Moore, Helen Smith, Bharath Narayanan, Nora Pashayan, Mark Emberton, Francesco Giganti, Vasilis Stavrinides
article en
1 citations

Abstract

Question What is the population distribution of growth rates and the natural history of prostate cancer? Findings Prostate cancer typically grows slowly, with considerable variation between individuals. On average, lesions take 17 years to grow from initiation to an MRI-detectable size. Clinical relevance Small lesions undetectable on MRI may take many years to reach a clinically significant size, posing a challenge for early detection, as it increases the risk of detecting indolent lesions that may never cause harm.

European Radiology
Cedars-Sinai Medical Center (US), University College London Hospitals NHS Foundation Trust (GB), Imperial College Healthcare NHS Trust (GB), University of Cambridge (GB), Faculty (United Kingdom) (GB), CRUK Lung Cancer Centre of Excellence (GB), University College London (GB)
Prostate Cancer Foundation, Oregon Health and Science University, Movember Foundation, Wellcome Trust, UK Research and Innovation, Cancer Research UK, National Institute for Health and Care Research, University College London, Prostate Cancer UK, University College London Hospitals NHS Foundation Trust, Knight Cancer Institute, Oregon Health and Science University, Medical Research Council, UCLH Biomedical Research Centre
Openalex Percentile: Top 2%
Prostate Cancer Diagnosis and Treatment
36.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Variation in prostate cancer growth rates in an MRI-based active surveillance cohort — Caroline M. Moore, Helen Smith, et al. · European Radiology (2026) | TGRS Research Map | TGRS